Institute of Pathology, University of Bern, Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Elife. 2017 Oct 4;6:e28366. doi: 10.7554/eLife.28366.
Aberrant alternative pre-mRNA splicing (AS) events have been associated with several disorders. However, it is unclear whether deregulated AS directly contributes to disease. Here, we reveal a critical role of the AS regulator epithelial splicing regulator protein 1 (ESRP1) for intestinal homeostasis and pathogenesis. In mice, reduced ESRP1 function leads to impaired intestinal barrier integrity, increased susceptibility to colitis and altered colorectal cancer (CRC) development. Mechanistically, these defects are produced in part by modified expression of ESRP1-specific isoforms differently activating the Wnt pathway. In humans, is downregulated in inflamed biopsies from inflammatory bowel disease patients. ESRP1 loss is an adverse prognostic factor in CRC. Furthermore, generation of dependent isoforms is altered in CRC and expression of a specific isoform predicts CRC patient survival. These findings indicate a central role of ESRP1-regulated AS for intestinal barrier integrity. Alterations in ESRP1 function or expression contribute to intestinal pathology.
异常的选择性剪接(AS)事件与多种疾病有关。然而,目前尚不清楚剪接失调是否直接导致疾病。在这里,我们揭示了 AS 调节剂上皮剪接调节蛋白 1(ESRP1)在肠道稳态和发病机制中的关键作用。在小鼠中,ESRP1 功能降低会导致肠道屏障完整性受损、结肠炎易感性增加和结直肠癌(CRC)发展改变。从机制上讲,这些缺陷部分是由 ESRP1 特异性异构体的表达改变产生的,这些异构体通过不同的方式激活 Wnt 途径。在人类中,炎症性肠病患者的炎症活检中下调了 。ESRP1 的缺失是 CRC 的一个不利预后因素。此外,CRC 中依赖的 异构体的产生发生改变,并且特定 异构体的表达可预测 CRC 患者的生存。这些发现表明 ESRP1 调节的 AS 对于肠道屏障完整性具有核心作用。ESRP1 功能或表达的改变导致肠道病理学改变。